PHIO PHARMACEUTICALS CORP. Class of Warrant or Right, Outstanding
PHIO PHARMACEUTICALS CORP. (PHIO) had Class of Warrant or Right, Outstanding of 13.39 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-06
- 2026-06-30: Class of Warrant or Right, Outstanding 13.39M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 13.39M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 13.53M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.60M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 13.39M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 13.39M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 13.53M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 7.60M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 6.60M shares 10-Q · filed 2026-08-06 | |
| 2025-03-31 | 6.62M shares 10-Q · filed 2026-05-07 | |
| 2024-12-31 | 1.93M shares 10-Q · filed 2026-08-06 | |
| 2024-09-30 | 1.29M shares 10-Q · filed 2025-11-13 | |
| 2023-12-31 | 703.53K shares 10-K · filed 2026-03-05 | |
| 2018-03-31 | 1.41M shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 1.41M shares 10-K · filed 2018-03-26 | |
| 2017-09-30 | 1.41M shares 10-Q/A · filed 2018-03-26 | 14.08M shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 1.41M shares 10-Q/A · filed 2018-03-26 | 14.08M shares 10-Q · filed 2017-08-10 |
| 2017-03-31 | 1.41M shares 10-Q/A · filed 2018-03-26 | 14.08M shares 10-Q · filed 2017-05-11 |
| 2016-12-31 | 14.08M shares 10-K · filed 2017-03-30 | |
| 2016-09-30 | 1.30M shares 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 2.56M shares 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 2.56M shares 10-Q · filed 2016-05-12 | |
| 2012-12-31 | 138.46K shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |